Arg-Gly-Asp-Ser

Arg-Gly-Asp-Ser （订货以CAS编码或英文名称为准）

Arg-Gly-Asp-Ser 是整联蛋白结合序列，抑制整联蛋白受体 (integrin receptor) 功能。Arg-Gly-Asp-Ser 直接并特异性地结合 pro-caspase-8，pro-caspase-9 和 pro-caspase-3，但不与 pro-caspase-1 结合。

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PL13846

分子式：C15H27N7O8

CAS号：91037-65-9

分子量：433.42

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PL13846-10mg	Medlife	10mg	≥99%	¥680.00	登录后可见
PL13846-50mg	Medlife	50mg	≥99%	¥2163.64	登录后可见
PL13846-100mg	Medlife	100mg	≥99%	¥3894.55	登录后可见
PL13846-200mg	Medlife	200mg	≥99%	待询	登录后可见
PL13846-500mg	Medlife	500mg	≥99%	待询	登录后可见
PL13846-10mM*1mLinDMSO	Medlife	10mM*1mLinDMSO	≥99%	¥754.18	登录后可见

中文名称：	精氨酰-甘氨酰-天冬氨酰-丝氨酸
中文别名：	H-精氨酸-甘氨酸-天冬氨酸-丝氨酸-OH;精氨酰-甘氨酰-天冬氨酰-丝氨酸;L-精氨酰甘氨酰-L-alpha-天冬氨酰-L-丝氨酸
英文名称：	Arg-Gly-Asp-Ser
英文别名：	L-Serine,L-arginylglycyl-L-a-aspartyl-;Arg-Gly-Asp-Ser;arginyl-glycyl-aspartyl-serine;H-Arg-Gly-Asp-Ser-OH;RGDS;RGDS peptide;2ACOH 2H2O;Arg-Gly-Asp-Ser-OH;fibronectin active fragment;FIBRONECTIN INHIBITOR;L-ARG-GLY-ASP-SER;L-Arg-Gly-L-Asp-L-Ser-OH;RGDS 1;Palmitoyl Oligopertide;Fibronectin tetrapeptide;C15H27N7O8;L-Arginylglycyl-L-alpha-aspartyl-L-serine;L-Serine, L-arginylglycyl-L-alpha-aspartyl-;L-Serine, N-(N-(N-L-arginylglycyl)-L-alpha-aspartyl)-;AK163508;3-[(S)-2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carboxy-2-hydroxy-ethyl)-succinamic acid;BDBM50241180;3450AH;AKO;L-Arginylglycyl-L-α-aspartyl-L-serine (ACI);L-Serine, N-[N-(N-L-arginylglycyl)-L-α-aspartyl]- (ZCI);102: PN: WO2008113030 SEQID: 103 unclaimed sequence;10: PN: JP2003089648 SEQID: 11 unclaimed;10: PN: WO03099465 SEQID: 11 claimed protein;10: PN: WO2020081717 SEQID: 10 claimed protein;110: PN: US20100136614 SEQID: 111 unclaimed sequence;11: PN: US20050142094 SEQID: 11 unclaimed sequence;11: PN: WO2013007839 SEQID: 52 claimed protein;12: PN: JP2004000070 SEQID: 14 unclaimed protein;12: PN: WO0044808 TABLE: 4 unclaimed sequence;12: PN: WO03089607 SEQID: 12 claimed sequence;13: PN: US20100028387 SEQID: 13 claimed protein;13: PN: US20140004158 SEQID: 14 claimed sequence;13: PN: US6111069 SEQID: 6 claimed protein;13: PN: WO2017072759 SEQID: 13 claimed sequence;14: PN: JP2003210166 SEQID: 14 claimed protein;14: PN: JP2004049921 SEQID: 14 unclaimed protein;16: PN: EP3415165 SEQID: 16 claimed protein;16: PN: KR20140027031 SEQID: 17 claimed protein;16: PN: WO0105991 SEQID: 17 unclaimed sequence;16: PN: WO2022027020 PAGE: 57 claimed sequence;172: PN: US20080107614 SEQID: 134 unclaimed sequence;18: PN: US20040228913 SEQID: 11 claimed sequence;18: PN: US6147189 SEQID: 6 claimed protein;18: PN: WO2011163398 SEQID: 15 unclaimed protein;1: PN: JP2002369878 SEQID: 11 unclaimed sequence;1: PN: JP2007230891 SEQID: 1 claimed protein;1: PN: JP2008195682 SEQID: 1 unclaimed protein;1: PN: JP2008195683 SEQID: 1 unclaimed protein;1: PN: JP2023038840 SEQID: 1 claimed sequence;1: PN: KR20150027940 SEQID: 2 claimed sequence;1: PN: US20040023391 PAGE: 9 claimed protein;1: PN: US20150064143 SEQID: 1 claimed sequence;1: PN: US6013628 SEQID: 16 unclaimed protein;1: PN: US6043216 SEQID: 1 claimed sequence;1: PN: WO0178529 PAGE: 26 unclaimed sequence;1: PN: WO0187071 SEQID: 2 unclaimed sequence;1: PN: WO2012124998 SEQID: 3 claimed protein;1: PN: WO2012135813 PAGE: 8 claimed protein;1: PN: WO2014172355 SEQID: 1 claimed protein;1: PN: WO2017036533 SEQID: 1 claimed protein;1: PN: WO2017040335 SEQID: 210 claimed sequence;1: PN: WO2017059312 SEQID: 1 claimed sequence;1: PN: WO2017160862 SEQID: 7 claimed protein;1: PN: WO2018201051 SEQID: 383 claimed protein;1: PN: WO2019104154 SEQID: 1 claimed protein;1: PN: WO2020097235 SEQID: 31 claimed sequence;1: PN: WO2022234536 SEQID: 1 claime...
CAS号：	91037-65-9
分子式：	C15H27N7O8
分子量：	433.42
详细描述	Arg-Gly-Asp-Ser 是整联蛋白结合序列，抑制整联蛋白受体 (integrin receptor) 功能。Arg-Gly-Asp-Ser 直接并特异性地结合 pro-caspase-8，pro-caspase-9 和 pro-caspase-3，但不与 pro-caspase-1 结合。

搜索质检报告(COA)